Gelteq Limited (GELS) Stock price, Description, News & Info

#Thinksabio latest news

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy MarketStudy to Support Potential FDA Approval via 505(b)(2) Pathway